The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function

Despite the extraordinary success of HIV-1 antiretroviral therapy in prolonging life, infected individuals face lifelong therapy because of a reservoir of latently-infected cells that harbor replication competent virus. Recently, compounds have been identified that can reverse HIV-1 latency in vivo....

Descripción completa

Detalles Bibliográficos
Autores principales: Clutton, G., Xu, Y., Baldoni, P. L., Mollan, K. R., Kirchherr, J., Newhard, W., Cox, Kara, Kuruc, J. D., Kashuba, A., Barnard, R., Archin, N., Gay, C. L., Hudgens, M. G., Margolis, D. M., Goonetilleke, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969750/
https://www.ncbi.nlm.nih.gov/pubmed/27480951
http://dx.doi.org/10.1038/srep30749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969750/
https://www.ncbi.nlm.nih.gov/pubmed/27480951
http://dx.doi.org/10.1038/srep30749

Ejemplares similares